Tirzepatide/Semaglutide

Semaglutide is a GLP-1 agonist that increases insulin release, lowering the amount of glucagon released, delaying gastric emptying, and reducing appetite. Tirzapatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Used for weight-loss management in combination with diet and exercise to reduce appetite, regulate blood sugar levels, and promote weight loss.